Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2026-06-21 @ 1:52 AM
Study NCT ID:
NCT04419558
Status:
TERMINATED
Last Update Posted:
2024-08-12
First Post:
2020-06-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Sponsor:
FibroGen
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Idiopathic Pulmonary Fibrosis | View |